Rhonda Lynette Hellums - Chief Financial Officer, Director at Silence Therapeutics plc

Issuer-level insider activity

Role
Chief Financial Officer, Director
Issuer ticker
SLN on Nasdaq, SLNCF on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Rhonda Lynette Hellums since 14 Oct 2025

Reported holdings for Rhonda Lynette Hellums in Silence Therapeutics plc

Form 4 holding Chief Financial Officer, Director

Silence Therapeutics plc

Security class
Employee Share Option (Right to Buy)
Shares / value
375,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Rhonda Lynette Hellums in Silence Therapeutics plc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .